Systemic Sclerosis News Today

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the release of a Special Report evaluating...

Area under the curve for routine biomarkers distinguished infected and noninfected adults with inflammatory diseases.

MELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational therapy FT011 for the treatment of systemic sclerosis (scleroderma), having previously granted Orphan Drug Designation.[1] The Fast Track Designation was granted based on r

In patients with SSc, the presence of inflammatory arthritis is significantly associated with diffuse disease, musculoskeletal manifestations, myositis, and sicca.

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The

Scleroderma is a complex autoimmune disorder that affects connective tissues, characterized by skin tightening and internal organ fibrosis. You can manage its symptoms by staying warm or by using saline soaks or warm water.

Over 140 healthcare professionals from the Middle East and Africa gathered for the third edition of the Interstitial Lung Disease (ILD) Summit to discuss the latest developments in the treatment and management of respiratory conditions.

Weakened bioavailability of mycophenolate mofetil could require adjustments in treatment.

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today a new publication in Antimicrobial Agents and Chemotherapy1 detailing the...

Patients with idiopathic pulmonary fibrosis who required dose reductions had similar all-cause mortality and death rates vs patients on the full dose.